Biomarkers in Liver Disease
In the past decade there has been a major sea change in the way disease is diagnosed and investigated due to the advent of high throughput technologies, such as microarrays, lab on a chip, proteomics, genomics, lipomics, metabolomics etc. These advances have enabled the discovery of new and novel ma...
| Other Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Dordrecht
Springer Netherlands
2020, 2020
|
| Series: | Biomarkers in Disease: Methods, Discoveries and Applications
|
| Subjects: | |
| Online Access: | |
| Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- Alanine Aminotransferase
- PTX3 as a biomarker of liver disease
- Biological Functions and its Neo-epitope as Hepatic Fibrosis Biomarker
- Fibrinogen α-chain as a serum marker of liver disease
- Monocyte chemotactic protein-1 (cytokine, receptors,and gene polymorphisms) in hepatitis
- Biomarkers for Recurrence of Hepatocellular Carcinoma.-Graft-derived cell-free DNA as a biomarker in liver transplantation
- Serum sialic acid as a biomarker in liver disease
- CD133 and EpCAM as Biomarkers in Liver Diseases
- Traditional markers in liver disease
- Biomarkers of extracellular matrix remodeling in liver diseases
- biological aspects and clinical applications
- microRNA-155 and microRNA-196b in hepatitis C virus infection
- Immunological biomarkers in liver transplantation
- Phosphatidylethanol and alcohol use in liver disease patients
- Interaction of sialyltransferases, sialidases and sialic acids in liver diseases and applications to biomarker discovery
- Biomarkers to monitor graft function following liver transplantation
- YKL-40 as a biomarker of liver diseases
- Peripheral venous, portal venous, hepatic venous, arterial and intrahepatic cytokine levels as biomarkers and functional correlations
- Histological Biomarkers of Non-Alcoholic Fatty Liver Disease
- Vascular cell adhesion molecule-1 (vcam-1) expression in liver disease
- Bilirubin as a biomarker in liver disease
- Hydroxyproline as a biomarker in liver disease
- Genetic biomarkers of paracetamol-induced acute liver failure